{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:22:48Z","timestamp":1794360168170,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"44","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,18]]},"DOI":"10.1038\/s41388-026-03996-2","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:56:25Z","timestamp":1790614585000},"page":"4827-4842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SPTLC2-driven sphingolipid reprogramming of neutrophils impairs anti-tumour immunity and drives liver cancer progression"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0359-3118","authenticated-orcid":false,"given":"Zhe","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-3402","authenticated-orcid":false,"given":"Zhibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0883-0722","authenticated-orcid":false,"given":"Ranran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"3996_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19:151\u201372.","journal-title":"Nat Rev Clin Oncol"},{"key":"3996_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature14407","volume":"522","author":"V Finisguerra","year":"2015","unstructured":"Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson AA, et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature. 2015;522:349\u201353.","journal-title":"Nature"},{"key":"3996_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41392-025-02363-z","volume":"10","author":"I Ozel","year":"2025","unstructured":"Ozel I, Sha G, B\u0119dzi\u0144ska A, Pylaeva E, Naumova Y, Thiel I, et al. Neutrophil-specific targeting of STAT3 impairs tumor progression via the expansion of cytotoxic CD8+ T cells. Signal Transduct Target Ther. 2025;10:279.","journal-title":"Signal Transduct Target Ther"},{"key":"3996_CR4","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1039\/C8CC02003E","volume":"54","author":"C Barnaba","year":"2018","unstructured":"Barnaba C, Ravula T, Medina-Meza IG, Im SC, Anantharamaiah GM, Waskell L, et al. Lipid-exchange in nanodiscs discloses membrane boundaries of cytochrome-P450 reductase. Chem Commun (Camb). 2018;54:6336\u20139.","journal-title":"Chem Commun (Camb)"},{"key":"3996_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk1045","volume":"10","author":"T Abimannan","year":"2024","unstructured":"Abimannan T, Parthibane V, Le SH, Vijaykrishna N, Fox SD, Karim B, et al. Sphingolipid biosynthesis is essential for metabolic rewiring during TH17 cell differentiation. Sci Adv. 2024;10:eadk1045.","journal-title":"Sci Adv"},{"key":"3996_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-024-07098-5","volume":"627","author":"AG York","year":"2024","unstructured":"York AG, Skadow MH, Oh J, Qu R, Zhou QD, Hsieh WY, et al. IL-10 constrains sphingolipid metabolism to limit inflammation. Nature. 2024;627:628\u201335.","journal-title":"Nature"},{"key":"3996_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s12276-022-00766-4","volume":"54","author":"GT Kim","year":"2022","unstructured":"Kim GT, Devi S, Sharma A, Cho KH, Kim SJ, Kim BR, et al. Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response. Exp Mol Med. 2022;54:573\u201384.","journal-title":"Exp Mol Med"},{"key":"3996_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg8817","volume":"9","author":"S Ma","year":"2024","unstructured":"Ma S, Sandhoff R, Luo X, Shang F, Shi Q, Li Z, et al. Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos. Sci Immunol. 2024;9:eadg8817.","journal-title":"Sci Immunol"},{"key":"3996_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-022-05637-6","volume":"614","author":"MK Handzlik","year":"2023","unstructured":"Handzlik MK, Gengatharan JM, Frizzi KE, McGregor GH, Martino C, Rahman G, et al. Insulin-regulated serine and lipid metabolism drive peripheral neuropathy. Nature. 2023;614:118\u201324.","journal-title":"Nature"},{"key":"3996_CR10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i38.112489","volume":"31","author":"C Mazziotta","year":"2025","unstructured":"Mazziotta C, Rotondo JC. Unraveling the role of flotillin-1 in driving hepatocellular carcinoma progression through transcription factor E3-mediated Golgi stress response. World J Gastroenterol. 2025;31:112489.","journal-title":"World J Gastroenterol"},{"key":"3996_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41388-024-03004-5","volume":"43","author":"X Yu","year":"2024","unstructured":"Yu X, Li C, Wang Z, Xu Y, Shao S, Shao F, et al. Neutrophils in cancer: dual roles through intercellular interactions. Oncogene. 2024;43:1163\u201377.","journal-title":"Oncogene"},{"key":"3996_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37515-8","volume":"14","author":"JY Chung","year":"2023","unstructured":"Chung JY, Tang PC, Chan MK, Xue VW, Huang XR, Ng CS, et al. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma. Nat Commun. 2023;14:1794.","journal-title":"Nat Commun"},{"key":"3996_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1611365","volume":"16","author":"C Fuster-Anglada","year":"2025","unstructured":"Fuster-Anglada C, Corominas J, Marsal A, Llarch N, Iserte G, Sanduzzi-Zamparelli M, et al. Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages. Front Immunol. 2025;16:1611365.","journal-title":"Front Immunol"},{"key":"3996_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1472430","volume":"15","author":"MN Khan","year":"2024","unstructured":"Khan MN, Mao B, Hu J, Shi M, Wang S, Rehman AU, et al. Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC. Front Immunol. 2024;15:1472430.","journal-title":"Front Immunol"},{"key":"3996_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"KY Shen","year":"2024","unstructured":"Shen KY, Zhu Y, Xie SZ, Qin LX. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol. 2024;17:25.","journal-title":"J Hematol Oncol"},{"key":"3996_CR16","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.7150\/thno.104557","volume":"15","author":"W Bi","year":"2025","unstructured":"Bi W, Li X, Jiang Y, Gao T, Zhao H, Han Q, et al. Tumor-derived exosomes induce neutrophil infiltration and reprogramming to promote T-cell exhaustion in hepatocellular carcinoma. Theranostics. 2025;15:2852\u201369.","journal-title":"Theranostics"},{"key":"3996_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189231","volume":"1879","author":"X Pan","year":"2024","unstructured":"Pan X, Wang Q, Sun B. Multifaceted roles of neutrophils in tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2024;1879:189231.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3996_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188762","volume":"1877","author":"H Que","year":"2022","unstructured":"Que H, Fu Q, Lan T, Tian X, Wei X. Tumor-associated neutrophils and neutrophil-targeted cancer therapies. Biochim Biophys Acta Rev Cancer. 2022;1877:188762.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3996_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2021.09.011","volume":"522","author":"H Chen","year":"2021","unstructured":"Chen H, Zhou XH, Li JR, Zheng TH, Yao FB, Gao B, et al. Neutrophils: Driving inflammation during the development of hepatocellular carcinoma. Cancer Lett. 2021;522:22\u201331.","journal-title":"Cancer Lett"},{"key":"3996_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2052418","volume":"11","author":"ZZ Jiang","year":"2022","unstructured":"Jiang ZZ, Peng ZP, Liu XC, Guo HF, Zhou MM, Jiang D, et al. Neutrophil extracellular traps induce tumor metastasis through dual effects on cancer and endothelial cells. Oncoimmunology. 2022;11:2052418.","journal-title":"Oncoimmunology"},{"key":"3996_CR21","doi-asserted-by":"crossref","unstructured":"Feng M, Wang F, Liu X, Hao T, Zhang N, Deng M, et al. Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer. Cancer Biol Med. 2023;20:421\u201337.","DOI":"10.20892\/j.issn.2095-3941.2023.0019"},{"key":"3996_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1042\/EBC20220245","volume":"67","author":"E Ramon-Gil","year":"2023","unstructured":"Ramon-Gil E, Geh D, Leslie J. Harnessing neutrophil plasticity for HCC immunotherapy. Essays Biochem. 2023;67:941\u201355.","journal-title":"Essays Biochem"},{"key":"3996_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.484","volume":"11","author":"ZG Shan","year":"2021","unstructured":"Shan ZG, Chen J, Liu JS, Zhang JY, Wang TT, Teng YS, et al. Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-\u03b1-B7-H2-dependent pathway in human gastric cancer. Clin Transl Med. 2021;11:e484.","journal-title":"Clin Transl Med"},{"key":"3996_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101149","volume":"62","author":"P Wang","year":"2025","unstructured":"Wang P, Zhu P, Li ZY, Zhao YL, Mao FY, Peng LS, et al. Expression, regulation, function and clinical significance of B7-H6 on neutrophils in human gastric cancer. Neoplasia. 2025;62:101149.","journal-title":"Neoplasia"},{"key":"3996_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.962669","volume":"13","author":"L Cristinziano","year":"2022","unstructured":"Cristinziano L, Modestino L, Capone M, Madonna G, Mallardo D, Giannarelli D, et al. PD-L1+ neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab. Front Immunol. 2022;13:962669.","journal-title":"Front Immunol"},{"key":"3996_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1363454","volume":"15","author":"Z Lu","year":"2024","unstructured":"Lu Z, Wang X, Feng J, Chai W, Wang W, Wang Q, et al. Intratumoral CXCR4hi neutrophils display ferroptotic and immunosuppressive signatures in hepatoblastoma. Front Immunol. 2024;15:1363454.","journal-title":"Front Immunol"},{"key":"3996_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00398-3","volume":"11","author":"H Raskov","year":"2022","unstructured":"Raskov H, Orhan A, Gaggar S, G\u00f6genur I. Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy. Oncogenesis. 2022;11:22.","journal-title":"Oncogenesis"},{"key":"3996_CR28","doi-asserted-by":"crossref","unstructured":"Kaisar-Iluz N, Arpinati L, Shaul ME, Mahroum S, Qaisi M, Tidhar E, et al. The Bilateral Interplay between Cancer Immunotherapies and Neutrophils\u2019 Phenotypes and Sub-Populations. Cells. 2022;11:783.","DOI":"10.3390\/cells11050783"},{"key":"3996_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ijc.33991","volume":"151","author":"P Lecot","year":"2022","unstructured":"Lecot P, Ardin M, Dussurgey S, Alcazer V, Moudombi L, Pereira Abrantes M, et al. Gene signature of circulating platelet-bound neutrophils is associated with poor prognosis in cancer patients. Int J Cancer. 2022;151:138\u201352.","journal-title":"Int J Cancer"},{"key":"3996_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111415","volume":"40","author":"ME Spears","year":"2022","unstructured":"Spears ME, Lee N, Hwang S, Park SJ, Carlisle AE, Li R, et al. De novo sphingolipid biosynthesis necessitates detoxification in cancer cells. Cell Rep. 2022;40:111415.","journal-title":"Cell Rep"},{"key":"3996_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41747-z","volume":"14","author":"JH Sch\u00e4fer","year":"2023","unstructured":"Sch\u00e4fer JH, K\u00f6rner C, Esch BM, Limar S, Parey K, Walter S, et al. Structure of the ceramide-bound SPOTS complex. Nat Commun. 2023;14:6196.","journal-title":"Nat Commun"},{"key":"3996_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41388-024-03249-0","volume":"44","author":"X Zhai","year":"2025","unstructured":"Zhai X, Shen N, Guo T, Wang J, Xie C, Cao Y, et al. SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer progression. Oncogene. 2025;44:679\u201393.","journal-title":"Oncogene"},{"key":"3996_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50341-w","volume":"15","author":"M Hering","year":"2024","unstructured":"Hering M, Madi A, Sandhoff R, Ma S, Wu J, Mieg A, et al. Sphinganine recruits TLR4 adaptors in macrophages and promotes inflammation in murine models of sepsis and melanoma. Nat Commun. 2024;15:6067.","journal-title":"Nat Commun"},{"key":"3996_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13578-025-01362-5","volume":"15","author":"J Zeng","year":"2025","unstructured":"Zeng J, Way G, Wu N, Jiang X, Tai YL, Zhao D, et al. Transcriptomics, lipidomics, and single-nucleus RNA sequencing integration: exploring sphingolipids in MASH-HCC progression. Cell Biosci. 2025;15:34.","journal-title":"Cell Biosci"},{"key":"3996_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41586-024-07787-1","volume":"633","author":"M Soula","year":"2024","unstructured":"Soula M, Unlu G, Welch R, Chudnovskiy A, Uygur B, Shah V, et al. Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer. Nature. 2024;633:451\u20138.","journal-title":"Nature"},{"key":"3996_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv0558","volume":"11","author":"X Zhang","year":"2025","unstructured":"Zhang X, Lao M, Sun K, Yang H, He L, Liu X, et al. Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma. Sci Adv. 2025;11:eadv0558.","journal-title":"Sci Adv"},{"key":"3996_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07040-x","volume":"24","author":"F Meng","year":"2025","unstructured":"Meng F, Nian F, Feng H, Chen Z, Jiang Q, Zhang F, et al. SGMS2+\u2009macrophages enhance NR4A3hi NK cell infiltration to improve prognosis and PD-1 treatment efficacy in hepatocellular carcinoma. J Transl Med. 2025;24:13.","journal-title":"J Transl Med"},{"key":"3996_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45084-7","volume":"15","author":"R Sun","year":"2024","unstructured":"Sun R, Lei C, Xu Z, Gu X, Huang L, Chen L, et al. Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Nat Commun. 2024;15:966.","journal-title":"Nat Commun"},{"key":"3996_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12272-023-01454-1","volume":"46","author":"H Jang","year":"2023","unstructured":"Jang H, Ojha U, Jeong JH, Park KG, Lee SY, Lee YM. Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K\/Akt\/mTOR pathway. Arch Pharm Res. 2023;46:629\u201345.","journal-title":"Arch Pharm Res"},{"key":"3996_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-026-01780-z","volume":"19","author":"J Li","year":"2026","unstructured":"Li J, Huang C, Tang P, Wu R, Wu Q, Zhang C. The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications. J Hematol Oncol. 2026;19:16.","journal-title":"J Hematol Oncol"},{"key":"3996_CR41","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly A, Zhao W, Wickstr\u00f6m S, Arn\u00e9r E, Kiessling R. Reactive oxygen species: Janus-faced molecules in the era of modern cancer therapy. J Immunother Cancer. 2024;12:e009409.","DOI":"10.1136\/jitc-2024-009409"},{"key":"3996_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07098-3","volume":"15","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhao Z, Li B, Huan S, Li Z, Xie J, et al. ACSL4-mediated lipid rafts prevent membrane rupture and inhibit immunogenic cell death in melanoma. Cell Death Dis. 2024;15:695.","journal-title":"Cell Death Dis"},{"key":"3996_CR43","doi-asserted-by":"crossref","unstructured":"Liu S, Tao J, Duan F, Li H, Tan H. HHcy Induces pyroptosis and atherosclerosis via the lipid raft-mediated NOX-ROS-NLRP3 inflammasome pathway in apoE-\/- Mice. Cells. 2022;11:2438.","DOI":"10.3390\/cells11152438"},{"key":"3996_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13167","volume":"55","author":"B Li","year":"2022","unstructured":"Li B, Qin Y, Yu X, Xu X, Yu W. Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis. Cell Prolif. 2022;55:e13167.","journal-title":"Cell Prolif"},{"key":"3996_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107648","volume":"213","author":"J Wan","year":"2025","unstructured":"Wan J, Hu Z, Zhu H, Li J, Zheng Z, Deng Z, et al. The essential role of sphingolipids in TRPC5 ion channel localization and functionality within lipid rafts. Pharm Res. 2025;213:107648.","journal-title":"Pharm Res"},{"key":"3996_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202307752","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu Y, Niu R, Deng R, Wang Y, Song S, Zhang H. Multi-enzyme co-expressed nanomedicine for anti-metastasis tumor therapy by up-regulating cellular oxidative stress and depleting cholesterol. Adv Mater. 2024;36:e2307752.","journal-title":"Adv Mater"},{"key":"3996_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12989-025-00621-0","volume":"22","author":"T Hornstein","year":"2025","unstructured":"Hornstein T, Spannbrucker T, Unfried K. Combustion-derived carbon nanoparticles cause delayed apoptosis in neutrophil-like HL-60 cells in vitro and in primed human neutrophilic granulocytes ex vivo. Part Fibre Toxicol. 2025;22:6.","journal-title":"Part Fibre Toxicol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03996-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03996-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03996-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:03:00Z","timestamp":1793142180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03996-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":47,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2026,11,18]]}},"alternative-id":["3996"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03996-2","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods in this study were performed in accordance with the relevant guidelines and regulations. Human-related experiments using clinical tissue microarrays were approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval No.: 2025-KY-0969). Written informed consent was obtained from all participants. All animal experiments were approved by the Animal Ethics Committee of Zhengzhou University (Approval Number: ZZU-LAC20230210) and performed following the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}